# STING‐ATF3/type I interferon crosstalk: A potential target to improve anti‐tumour immunity in chemotherapy‐treated urothelial carcinoma

**Authors:** Alexandra Fauvre, Margot Machu, Audrey Merienne, Nadia Vie, Thomas Bessede, Mathilde Robin, Veronique Garambois, Clara Taffoni, Nadine Laguette, Nadine Gervois‐Segain, Anne Jarry, Nathalie Labarriere, Yves Allory, Christel Larbouret, Laurent Gros, Diego Tosi, David B. Solit, Philippe Pourquier, Nadine Houédé, Celine Gongora

PMC · DOI: 10.1002/ctm2.70011 · Clinical and Translational Medicine · 2024-09-13

## Full-text entities

- **Genes:** ATF3 (activating transcription factor 3) [NCBI Gene 467], STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}
- **Diseases:** tumour (MESH:D009369), urothelial carcinoma (MESH:D014523)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11397130/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11397130/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC11397130/full.md

---
Source: https://tomesphere.com/paper/PMC11397130